Details of the Drug Combinations

General Information of This Drug (ID: DMUOK4C)

Drug Name

Lisinopril DMUOK4C

Synonyms

Acerbon; Acercomp; Alapril; Carace; Cipral; Cipril; Coric; Doneka; Hipril (TN); Inhibril; Inopril; LPR; Linopril; Linvas; Lipril; Lisinal; Lisinopril (INN); Lisinopril (anhydrous); Lisinopril anhydrous; Lisinoprilum; Lisinoprilum [Latin]; Lisipril; Lisoril; Lispril; Longes; Loril; Lysinopril; MK 521; MK 522; MK-521; Noperten; Novatec; Presiten; Prinil; Prinivil; Prinivil (TN); Sinopril; Sinopryl; Tensopril; Tensopril (TN); Tensyn; Tersif; Vivatec; Zestril; Zestril (TN)

Indication

Disease Entry	ICD 11	Status	REF
Chronic heart failure	BD1Z	Approved	[1]
Hypertension	BA00-BA04	Approved	[2]
Myocardial infarction	BA41-BA43	Approved	[1]
Coronavirus Disease 2019 (COVID-19)	1D6Y	Investigative	[3]
High blood pressure	BA00	Investigative	[1]
------------------------------------------------------------------------------------

Therapeutic Class

Antihypertensive Agents

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

13 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Lisinopril + Losartan	DC2CU79	Losartan	Kidney Disease	[4]
Lisinopril + Amlodipine	DCKEH45	Amlodipine	Type 1 Diabetes	[5]
Lisinopril + Telmisartan	DCOC4OX	Telmisartan	Kidney, Polycystic	[6]
Lisinopril + Aleglitazar	DCY4YCZ	Aleglitazar	Diabetes Mellitus Type 2	[7]
Lisinopril + Nizatidine	DCVMJ9I	Nizatidine	Gastroparesis	[8]
Simvastatin + Lisinopril	DC1DARC	Simvastatin	Diabetic Nephropathy	[9]
Lisinopril + Pravastatin	DCAQXPO	Pravastatin	Breast Carcinoma	[10]
Lisinopril + Carvedilol	DCULCLN	Carvedilol	Breast Carcinoma	[10]
Lisinopril + Telmisartan	DC4QOFN	Telmisartan	Kidney, Polycystic	[11]
Chlorthalidone + Lisinopril	DCM2S0Z	Chlorthalidone	Hypertension	[12]
Chlorthalidone + Lisinopril	DCADO04	Chlorthalidone	Hypertension	[12]
Lisinopril + Amlodipine	DCDVFOB	Amlodipine	Pediatric Hypertension	[13]
Lisinopril + Prednisolone	DC3BBMB	Prednisolone	Glomerulonephritis	[14]
------------------------------------------------------------------------------------


⏷ Show the Full List of 13 DrugCom(s)

References

1	Lisinopril FDA Label
2	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3	Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Am Heart Assoc. 2020 Apr 7;9(7):e016219.
4	ClinicalTrials.gov (NCT00555217) VA NEPHRON-D: Diabetes iN Nephropathy Study
5	ClinicalTrials.gov (NCT00337298) The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes
6	ClinicalTrials.gov (NCT00283686) HALT Progression of Polycystic Kidney Disease Study A
7	ClinicalTrials.gov (NCT01398267) A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril
8	ClinicalTrials.gov (NCT02232308) Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects
9	ClinicalTrials.gov (NCT00004266) Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes
10	ClinicalTrials.gov (NCT04190433) Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial
11	ClinicalTrials.gov (NCT01885559) HALT Progression of Polycystic Kidney Disease Study B
12	ClinicalTrials.gov (NCT02847338) Comparison of Optimal Hypertension Regimens
13	ClinicalTrials.gov (NCT03461003) N-of-1 Trials In Children With Hypertension
14	ClinicalTrials.gov (NCT04662723) Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.